(Q43265600)

17 November 2017

title

New targets for antipsychotics (English)

1 reference

17 November 2017

Hugh M Jones

1

1 reference

17 November 2017

Lyn S Pilowsky

series ordinal

2

1 reference

17 November 2017

publication date

1 January 2002

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 November 2017

published in

1 reference

17 November 2017

volume

2

1 reference

17 November 2017

issue

1

1 reference

17 November 2017

page(s)

61-68

1 reference

Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Preventing severe mental illnesses--new prospects and ethical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Limbic selectivity of clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Treatment of schizophrenia with ergot derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Modulation of N-methyl-D-aspartate receptor function by glycine transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

The profiles of clinical deterioration in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Rationale for the study of early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

Pharmacogenetic prediction of clozapine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.1.61

21 January 2018

Identifiers

DOI

10.1586/14737175.2.1.61

1 reference

17 November 2017

1 reference